Dental, Oral & Craniofacial
Tissue Regeneration Consortium
Tissue Regeneration Consortium
Portfolio
| Principal Investigator(s) | ITP Project Title | Technology Type |
|---|---|---|
| Bone | ||
| Tara Aghaloo, DDS, MD, PhD (University of California Los Angeles) | Stem cell-based therapies for bone regeneration around ailing dental implants | Biologic‑Device |
| Yang Chai, DDS, PhD (University of Southern California) | Calvarial bone regeneration using 3D printed scaffold and bone marrow aspirate | Biologic‑Device |
| Joseph Fiorellini, DMD, DMedSc (Penn Dental Medicine), George Kay, DMD (RevBio) | Optimization of a Novel Organic-Mineral Bone Adhesive for Dental Bone Grafting (Tetranite) | Device |
| Andrew Brown, PhD (Emergence Dental)/Stephen LeBeau, PhD (nanoMAG) | AmpliMag: Form Stable, Resorbable Barrier Membrane | Device |
| Ari Wes, MD (Ostiio) | Ostiio: A Smart, Fully-Implantable CMF Distractor | Device |
| William Giannobile, DDS, DMedSc (Harvard University) | Abaloparatide to Treat Alveolar Bone Loss for Dental Implant Reconstruction | Biologic‑Drug |
| Periodontal Tissues | ||
| Peter Alff, PhD (Oraxsys Therapeutics) | Immunomodulatory Strategies to Treat Periodontal Disease | Biologic |
| Salivary Gland | ||
| Isabelle Lombaert, PhD (University of Michigan)/Michael Passineau, PhD (Allegheny Health Network) | Non-viral Aquaporin-1 Gene Therapy to Restore Salivary Flow in Patients Suffering from Radiation-induced Xerostomia, Michael Passineau, PhD (Allegheny Health Network)/Isabelle Lombaert, PhD (University of Michigan) | Biologic‑Device |
| Sarah Knox, PhD (University of California San Francisco) | Hydronovo: Regenerating the salivary gland using an injectable hydrogel | Drug‑Device |
| Soft Tissue (Nerve, Muscle, Skin, Fat, Other) | ||
| Robby Lane, MBA (Amend Surgical, Inc.) | Suture-less Trigeminal Nerve Repair Device | Device |
| Kevin Healy, PhD (University of California Berkeley) | Bioinspired hydrogels for craniofacial muscle regeneration | Device |
| Derrick Wan, MD (Stanford University) | Transdermal deferoxamine to enhance fat graft retention for reconstruction of irradiated soft tissue defects | Drug‑Device |
| Geoffrey Gurtner, MD (Stanford University) | Prevention of scar formation in the skin using topical focal adhesion kinase inhibitors | Drug‑Device |
| Jamie Shaikoski, PhD (Amend Surgical, Inc.) | Amend Tissue Tape™ for Oral Wound Care | Device |
| Michael Longaker, MD, MBA (Stanford University) | Local injection of verteporfin to promote wound repair via regeneration without scarring in primary cleft lip repair | Drug |
| Phillip Messersmith, PhD (UC Berkeley) and Ellen Heber-Katz, PhD (Lankenau Institute for Medical Research) | Drug induced periodontal regeneration | Drug |
| Jon-Paul Pepper, MD (Stanford University) | Drug loaded, bioprinted fibrin scaffolds for use during cranial nerve repair surgery | Drug-Device |
| Teeth/Dental Pulp | ||
| Luiz Bertassoni, DDS, PhD (Oregon Health and Science University)/Pamela Yelick, PhD (Tufts University) | REGEndogel: A Bioinspired Hydrogel System for Endodontic Therapy | Device |
| Steven Bloembergen, PhD (GreenMark Biomedical) | Targeted Remineralization Treatment Using Mineral Loaded Starch Nanoparticle | Device |
| Juan Taboas, PhD/Herb Ray, DMD (University of Pittsburgh) | Commercialization of Vital-Dent | Device |
| Temporomandibular Joint | ||
| Denis Evseenko, MD, PhD (University of Southern California) | Novel drug candidate for therapy of arthritis of the temporomandibular joint | Drug |
Currently Supported ITP Portfolio
Institution
Tissue Addressed
Technology Type
